Food effect studies and drug label recommendations: A review of recently approved oncology products.

被引：1
|
作者：
Farha, Mark
Masson, Eric
Tomkinson, Helen
Mugundu, Ganesh
机构：
[1] AstraZeneca, Waltham, MA USA
[2] AstraZeneca, Early Clin Dev, Quantitat Clin Pharmacol, Waltham, MA USA
[3] AstraZeneca, Early Clin Dev, Quantitat Clin Pharmacol, Cambridge, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.2535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2535
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Review of the levels of trans fatty acids reported in different food products.
    Griguol, V.
    Leon-Camacho, M.
    Vicario, I. M.
    GRASAS Y ACEITES, 2007, 58 (01) : 87 - 98
  • [22] Oncology Drug Advisory Committee Recommendations and the US Food and Drug Administration's Actions
    Haslam, Alyson
    Gill, Jennifer
    Prasad, Vinay
    MAYO CLINIC PROCEEDINGS, 2020, 95 (02) : 424 - 426
  • [23] Screening of Natural Products and Approved Oncology Drug Libraries for Activity against Clostridioides difficile
    Rusha Pal
    Mohamed N. Seleem
    Scientific Reports, 10
  • [24] Screening of Natural Products and Approved Oncology Drug Libraries for Activity against Clostridioides difficile
    Pal, Rusha
    Seleem, Mohamed N.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [25] Accelerated Approval of Oncology Products: The Food and Drug Administration Experience
    Johnson, John R.
    Ning, Yang-Min
    Farrell, Ann
    Justice, Robert
    Keegan, Patricia
    Pazdur, Richard
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (08) : 636 - 644
  • [26] Impact of Oncology Drug Review Times on Public Funding Recommendations
    Hussain, Marya
    Wong, Chelsea
    Taguedong, Eddy
    Verma, Saurav
    Mahsin, Md
    Karim, Safiya
    Lee-Ying, Richard
    Ezeife, Doreen A.
    CURRENT ONCOLOGY, 2023, 30 (08) : 7706 - 7712
  • [27] COST-EFFECTIVENESS OBSERVATIONS AND ONCOLOGY DRUG REIMBURSEMENT RECOMMENDATIONS IN CANADA BY THE JOINT ONCOLOGY DRUG REVIEW
    Ciapanna, C. C.
    Yunger, S.
    Shum, D.
    Milliken, D.
    Longo, C. J.
    Aissa, F.
    VALUE IN HEALTH, 2010, 13 (03) : A51 - A51
  • [28] Analysis of US Food and Drug Administration Oncology Approvals on the Characterization of Hepatic Impairment Effect and Dosing Recommendations
    Yang, Derek Z.
    Alhadab, Ali
    Parivar, Kourosh
    Wang, Diane D.
    Elmeliegy, Mohamed
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (04) : 782 - 790
  • [29] Registration by the European Agency for the Evaluation of Medicinal products (EMEA) of oncology products approved by the Food and Drug Administration (FDA) under accelerated approval (AA) regulations.
    Talarico, L
    Pignatti, F
    Pazdur, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 541S - 541S
  • [30] ANALYSIS AND RECOMMENDATIONS - FOOD AND DRUG ADMINISTRATION ORGANIZATIONAL REVIEW
    MALEK, FV
    FOOD DRUG COSMETIC LAW JOURNAL, 1970, 25 (01): : 22 - 28
12345